Mary Sheahan
Directeur/Membre du Conseil chez CENTOGENE N.V.
Postes actifs de Mary Sheahan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CENTOGENE N.V. | Directeur/Membre du Conseil | 01/12/2022 | - |
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Directeur Financier/CFO | - | - |
Historique de carrière de Mary Sheahan
Statistiques
Internationale
| Allemagne | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Director of Finance/CFO | 1 |
Sectorielle
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CENTOGENE N.V. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Mary Sheahan
- Expérience
